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in the structural variations of the human 
genome. This evidence includes the 
sheer number of repetitive elements, the 
de novo transposition/insertion/muta-
tion rates, the fact that similar elements 
(e.g., Alu-Alu, LINE-LINE) can act as 
substrates for homologous recombina-
tion and can generate CNVs by nonal-
lelic homologous recombination (NAHR), 
and that such elements can provide 
microhomology for priming polymerase 
extension during template switching in 
replication-based mechanisms (Zhang 
et al., 2009).
The junk DNA has come out of the 
closet or garage (depending on your 
favorite euphemism) and begun to reveal 
its immense value to genome evolution 
and human biology. It has certainly been 
fascinating to witness the transforma-
tion of human repetitive sequences from 
a nuisance that needs to be quenched 
during hybridizations to a central player 
in structural variation, arguably the most 
common form of genetic variation in 
humans and one that figures prominently 
in evolution and disease.
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Although amyloid plaques and neuro-
fibrillary tangles are the classic hallmarks 
of Alzheimer’s disease (AD) pathology, 
AD is also characterized by endosomal/
lysosomal abnormalities including the 
aberrant accumulation of subcellular 
structures involved in autophagy (the 
degradation of long-lived organelles and 
macromolecules), such as autophago-
somes, autolysosomes, and lysosomal 
dense bodies. Multiple lines of evidence 
now suggest a potential link between AD 
and autophagy. These include reports 
that presenilin 1, the gene most fre-
quently mutated in familial forms of AD, 
has a role in autophagocytosis or may 
have a more general function in subcel-
lular membrane trafficking (Esselens et 
al., 2004; Wilson et al., 2004; Sannerud 
and Annaert, 2009). In addition, disrup-
tion of the autophagy pathway promotes 
the deposition of amyloid plaques and 
accelerates neuronal loss (Pickford et 
al., 2008; Tooze and Schiavo, 2008).
In findings presented in this issue, Lee 
et al. (2010) strengthen this emerging 
connection between AD and autophagy 
and propose a mechanism that contrib-
utes to autophagosome accumulation 
observed in the disease. In normal cells, 
autophagosomes fuse with acidified lyso-
somes to promote the degradation of the 
autophagosome’s contents. Lee et al. 
now report that disease-causing muta-
tions in presenilin 1 impair the acidifica-
tion of lysosomes, thereby interfering with 
the subsequent autophagosome clear-
ance (Figure 1). Given that one of the sig-
natures of neurodegenerative disorders is 
accumulation of aggregates of misfolded 
protein, decreased turnover of protein 
(as observed in the current experiments) 
might contribute to the disease process. 
These provocative and potentially contro-
versial observations come amidst grow-
ing interest in molecular pathways that 
act in parallel (or possibly intersect) with 
the classical amyloid cascade.
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Mutations in the presenilin genes are the most common cause of familial forms of Alzheimer’s 
disease. Although it is well known for its role in the generation of amyloid peptide, Lee et al. (2010) 
now report that presenilin 1 deficiency also impacts maturation of the lysosomal proton pump, 
affecting autophagocytosis and protein turnover.
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Presenilins are best known for their 
catalytic function in the γ-secretase 
complex (Wakabayashi and De Strooper, 
2008). Disruption of this function by 
genetic or pharmacological inactivation 
interferes with the proteolytic process-
ing of many proteins including notch 
(critical for embryonic development), 
cadherins, and amyloid precursor pro-
tein (APP). It is the processing of APP to 
amyloid peptide that is usually consid-
ered the main contribution of presenilin 
1 to the pathogenesis of AD. To circum-
vent embryonic lethal notch phenotypes 
of presenilin 1 knockout mice, Lee et 
al. examine conditional knockout mice 
and mice with a hypomorphic allele. The 
authors also examine fibroblasts from 
familial AD patients and observe a simi-
lar impairment of lysosomal acidification. 
Given that the familial AD patients have a 
wild-type allele, in addition to a mutant 
allele, it is especially remarkable that 
fibroblasts from these individuals mirror 
the cellular phenotypes observed in the 
mutant mice. Although the mutations in 
presenilin 1 act in a genetically dominant 
manner, most lead to a loss of function 
in biochemical assays (Wakabayashi 
and De Strooper, 2008), and the data 
therefore suggest that the acidification 
defects observed are extremely sensi-
tive to small alterations in the function of 
presenilin 1.
To explain these phenomena, the 
authors propose an intriguing model that 
encompasses most of the observations in 
the paper. In brief, they suggest that pre-
senilin 1 is involved in the maturation of 
the V0a1 subunit of the bimodular v-type 
H+-ATPase proton pump that acidifies the 
lysosome. The authors provide evidence 
that this subunit, which appears as a 
glycosylated 120 kDa band in wild-type 
cells, migrates as an unglycosylated 100 
kDa precursor in cells lacking presenilin 1, 
and that due to the absence of glycosyla-
tion the immature V0a1 subunit remains 
stuck in the endoplasmic reticulum. 
Based on coimmunoprecipitation of pre-
senilin 1 with this immature V0a1 protein, 
and with subunits of the translocon and 
the oligosaccharyltransferase complex 
(Ruiz-Canada et al., 2009), the authors 
make the bold suggestion that prese-
nilin 1 presents the V0a1 subunit to the 
oligosaccharyltransferase that mediates 
N-glycan addition. Hence, in the absence 
of presenilin 1, N-glycosylation and trans-
port of the V0a1 subunit do not occur.
Several questions remain to be 
addressed before considering this model 
as established. For instance, the oligo-
saccharyltransferase adds Endo H gly-
cosidase-sensitive oligosaccharides to 
nascent proteins, whereas complex mod-
ifications occur later in the different Golgi 
compartments. Thus, it remains puzzling 
that no such Endo H-sensitive V0a1 inter-
mediate was identified in wild-type cells. 
Also the question of specificity remains 
unaddressed: three other V0a subunits 
are known (Marshansky and Futai, 2008), 
but it seems very unlikely that they are all 
equally affected by presenilin 1. Indeed, 
this would lead to extensive depletion of 
functional proton pumps in cells deficient 
in presenilin 1 and much more severe 
figure 1. Presenilin 1 and Autophagosome clearance
Depicted is a model explaining the role of presenilin 1 in the maturation and transport of the V0a1 subunit of the v-ATPase. In wild-type cells, presenilin 1 medi-
ates the posttranslational addition of a single N-glycan to the immature V0a1 subunit through interaction with the oligosaccharyltransferase (OST) complex and 
the translocon. Glycosylated V0a1 traffics via the Golgi complex to the lysosome where it contributes to a functional v-ATPase, which is required for acidification 
of lysosomes. Deficiency of presenilin 1 prevents glycosylation, stalling immature V0a1 in the endoplasmic reticulum, therefore impairing v-ATPase assembly 
and resulting in decreased lysosomal acidification. This in turn prevents autophagosome clearance during macroautophagy causing autophagic vacuoles to 
accumulate (figure concept provided by S. Sannerud).
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phenotypes than the ones observed. 
V0a1 subunits are implicated in vesicle 
fusion independent of their role in acidifi-
cation (Marshansky and Futai, 2008), and 
it might be interesting to study that aspect 
in more depth. Finally, full-length preseni-
lin 1, present in low amounts in the endo-
plasmic reticulum, is proposed to act as a 
Ca2+-leak channel (Tu et al., 2006), and it 
is unclear how the new proposed function 
relates to this previous one.
The new work underscores the impor-
tance of presenilin 1 function in the endo-
plasmic reticulum and confirms its role 
in subcellular trafficking, in particular in 
the autophagocytic/lysosomal pathways. 
Taking these intriguing observations as a 
starting point, further in-depth exploration 
of the precise mechanism will ultimately 
result in a better understanding of the myr-
iad functions of presenilins in health and 
disease.
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A revolution is occurring in our under-
standing of the genetic basis of common 
chronic diseases such as arthritis, Crohn’s 
disease, and cancer. Genome-wide asso-
ciation studies (GWAS) are identifying a 
plethora of common sequence variants of 
genes and of putative regulatory regions 
in or near genes that predispose an indi-
vidual to developing a particular disease. 
This flood of new information is made 
possible by dramatic improvements in 
the genotyping of DNA polymorphisms 
across the human genome, increased 
levels of statistical rigor during the inter-
pretation of results, and the large-scale 
collection of clinical resources. Never-
theless, doubts concerning the value 
of GWAS have arisen because in many 
cases a particular polymorphism only 
slightly increases an individual’s risk for 
developing that disorder. Hence, some 
researchers ask, how can such a small 
genetic effect provide useful insights into 
the mechanisms of the disease? How-
ever, more pertinent questions are, which 
particular genes mapped by GWAS are 
involved in the etiology or cause of the 
disease and how do these genes act?
One common disorder for which GWAS 
have been spectacularly successful is a 
severe form of gut inflammation called 
Crohn’s disease. GWAS of Crohn’s dis-
ease patients provided the first clues that 
alterations in the expression and activities 
of genes known to function in autophagy 
(i.e., the pathway that degrades intracel-
lular components, including pathogens) 
may predispose individuals to inflamma-
tion of the small intestine (Wellcome Trust 
Case Control Consortium, 2007). Two ear-
lier studies, one by Cadwell et al. (2008) 
and another by Saitoh et al. (2008), took 
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Information obtained from genome-wide association studies has cracked open the biology of 
common chronic diseases by identifying genes that predispose individuals to these disorders. 
Cadwell et al. (2010) now demonstrate that a viral infection, a toxic insult to the gut, commensal 
bacteria, and a Crohn’s disease susceptibility gene collude to cause inflammatory disease in the 
mouse gut.
